Download video

Osteoarthritis Update - Nancy Lane, M.D.

134 views

OnlineSymposia

11 years ago

Osteoarthritis Update - Nancy Lane, M.D.

Osteoarthritis Update - Nancy Lane, M.D.

Osteoarthritis Update - Nancy Lane, M.D.
5:01
Osteoarthritis Update - Nancy Lane, M.D.
by OnlineSymposia
Tanezumab and Similar Emerging Therapies – Nancy Lane, MD and Panel | #OACS 2020
2:00:56
Tanezumab and Similar Emerging Therapies – Nancy Lane, MD and Panel | #OACS 2020
by Arthritis Foundation
CORPORATE SCIENTISTS SPEAK ON DMOADS with Nancy Lane \& Lee Simon | #OACS 2020
1:49:00
CORPORATE SCIENTISTS SPEAK ON DMOADS with Nancy Lane \& Lee Simon | #OACS 2020
by Arthritis Foundation
Corporate Scientists Speak on Disease Modifying Osteoarthritis Drugs | OACS 2020
1:53:50
Corporate Scientists Speak on Disease Modifying Osteoarthritis Drugs | OACS 2020
by OACS Channel - Arthritis Foundation
Here’s a snippet of Dr. Nancy Lane's participation in ADARRC 2021.
0:45
Here’s a snippet of Dr. Nancy Lane's participation in ADARRC 2021.
by Advanced Academic Rheumatology Review Course ADARRC
Glucocorticoid-Induced Osteoporosis: A Translational Science Journey - Nancy Lane, M.D.
5:01
Glucocorticoid-Induced Osteoporosis: A Translational Science Journey - Nancy Lane, M.D.
by OnlineSymposia
A National Public Health Agenda for Osteoarthritis: 2020 Update
46:08
A National Public Health Agenda for Osteoarthritis: 2020 Update
by Osteoarthritis Action Alliance
Early Indication of Longer-Term Pain Relief with Anti-NGF Compounds
0:49
Early Indication of Longer-Term Pain Relief with Anti-NGF Compounds
by Arthritis Foundation
Anti-NGF Compounds May Be Indicated Later in Knee Osteoarthritis Disease Progression
2:17
Anti-NGF Compounds May Be Indicated Later in Knee Osteoarthritis Disease Progression
by Arthritis Foundation
Tanezumab and Similar Emerging Therapies – OACS 2020
2:00:56
Tanezumab and Similar Emerging Therapies – OACS 2020
by OACS Channel - Arthritis Foundation
Guidelines for Osteoarthritis of the Knee
2:23
Guidelines for Osteoarthritis of the Knee
by HCPLive
Considerations for Utilizing “PRN” or Treat to Target Approaches with Anti-NGF Compounds
1:40
Considerations for Utilizing “PRN” or Treat to Target Approaches with Anti-NGF Compounds
by Arthritis Foundation
Risk Mitigation Strategies in Patients Who Do Not Receive Pain Relief
1:24
Risk Mitigation Strategies in Patients Who Do Not Receive Pain Relief
by Arthritis Foundation
Expanded Osteoporosis Treatment Options on the Horizon
5:56
Expanded Osteoporosis Treatment Options on the Horizon
by Rheumatology Advisor